- CEO
- Zafer Karagöl
- Full Time Employees
- 98
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Denizli Turkey
- IPO Date
- Jul 6, 2012
- Business
- Aciselsan Acipayam Seluloz Sanayi ve Ticaret AS is a Turkey-based chemical manufacturing enterprise primarily engaged in the development, production, and marketing of carboxymethyl cellulose (CMC) and related specialty cellulose derivatives. Founded in 1973 and headquartered in Denizli, Turkey, the company operates as a subsidiary of Verusa Holding AS. Aciselsan manufactures and supplies a comprehensive portfolio of cellulose ether products across technical, semi-purified, and high-purity grades. Its primary product and service offerings include technical-grade carboxymethyl cellulose utilized as thickeners, rheology modifiers, binders, and sizing agents in oil and gas drilling fluids, detergents, textiles, paper manufacturing, ceramics, paints, mining, and building chemicals; purified and ultra-pure sodium carboxymethyl cellulose formulated for regulated applications in food and beverage processing, pharmaceuticals, cosmetics, personal care goods, and oral care products; and customized carboxymethyl starch along with tailored industrial cellulose chemical solutions engineered for specific manufacturing requirements. The company serves a diverse client base across industrial, commercial, and consumer goods sectors, marketing its products domestically within Turkey and exporting extensively to international markets across Europe, the Middle East, North Africa, Asia, and the Americas. In recent operations, Aciselsan has undertaken substantial strategic modernization and facility expansion projects at its Acipayam manufacturing plant to increase annual production capacity and upgrade processing automation for high-margin, high-purity grades. Additionally, the company commissioned on-site industrial rooftop solar photovoltaic power systems to self-generate renewable electricity, lower manufacturing energy costs, and decrease carbon intensity, while advancing research and development programs focused on specialized pharmaceutical-grade cellulose derivatives and bio-based industrial formulations to expand its global export footprint.